These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 3952742)

  • 1. Electromyographic, neuropathologic, and functional correlates in the cat as the result of tri-o-cresyl phosphate delayed neurotoxicity.
    Abou-Donia MB; Trofatter LP; Graham DG; Lapadula DM
    Toxicol Appl Pharmacol; 1986 Mar; 83(1):126-41. PubMed ID: 3952742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurologic manifestations of tri-O-cresyl phosphate delayed neurotoxicity in cats.
    Abou-Donia MB; Jensen DN; Lapadula DM
    Neurobehav Toxicol Teratol; 1983; 5(4):431-42. PubMed ID: 6646317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity of the cat to delayed neurotoxicity induced by O-ethyl O-4-nitrophenyl phenylphosphonothioate.
    Abou-Donia MB; Graham DG; Kinnes CG
    Toxicol Appl Pharmacol; 1983 Mar; 68(1):54-65. PubMed ID: 6845375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain acetylcholinesterase, acid phosphatase, and 2',3'-cyclic nucleotide-3'-phosphohydrolase and plasma butyrylcholinesterase activities in hens treated with a single dermal neurotoxic dose of S,S,S-tri-n-butyl phosphorotrithioate.
    Abou-Donia MB; Abdo KM; Timmons PR; Proctor JE
    Toxicol Appl Pharmacol; 1986 Mar; 82(3):461-73. PubMed ID: 3952729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of delayed neurotoxicity in the mouse following chronic oral administration of tri-o-cresyl phosphate.
    Lapadula DM; Patton SE; Campbell GA; Abou-Donia MB
    Toxicol Appl Pharmacol; 1985 Jun; 79(1):83-90. PubMed ID: 4049409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disposition of [14C]tri-o-cresyl phosphate and its metabolites in various tissues of the male cat following a single dermal application.
    Nomeir AA; Abou-Donia MB
    Drug Metab Dispos; 1984; 12(6):705-11. PubMed ID: 6150819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of drug metabolism inducers on the delayed neurotoxicity and disposition of tri-o-cresyl phosphate in hens following a single intravenous administration.
    Konno N; Katoh K; Yamauchi T; Fukushima M
    J Toxicol Sci; 1988 Feb; 13(1):17-30. PubMed ID: 3385808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of delayed neurotoxic effect after tri-o-cresyl phosphate treatment in male Fischer 344 rats: biochemical, neurobehavioral, and neuropathological studies.
    Somkuti SG; Tilson HA; Brown HR; Campbell GA; Lapadula DM; Abou-Donia MB
    Fundam Appl Toxicol; 1988 Feb; 10(2):199-205. PubMed ID: 3356306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time-dependent changes of lipid peroxidation and antioxidative status in nerve tissues of hens treated with tri-ortho-cresyl phosphate (TOCP).
    Zhang LP; Wang QS; Guo X; Zhu YJ; Zhou GZ; Xie KQ
    Toxicology; 2007 Sep; 239(1-2):45-52. PubMed ID: 17662514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the metabolism of the neurotoxic tri-o-cresyl phosphate. Distribution, excretion, and metabolism in male cats after a single, dermal application.
    Nomeir AA; Abou-Donia MB
    Toxicology; 1986 Jan; 38(1):15-33. PubMed ID: 3942008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous toxicity and delayed neurotoxicity of organophosphates in the scaleless hen.
    Cisson CM; Wilson BW
    Toxicol Appl Pharmacol; 1983 Mar; 67(3):310-21. PubMed ID: 6845361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testicular toxicity following oral administration of tri-o-cresyl phosphate (TOCP) in roosters.
    Somkuti SG; Lapadula DM; Chapin RE; Lamb JC; Abou-Donia MB
    Toxicol Lett; 1987 Aug; 37(3):279-90. PubMed ID: 3617103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histopathological assessment of triphenyl phosphite neurotoxicity in the hen.
    Carrington CD; Brown HR; Abou-Donia MB
    Neurotoxicology; 1988; 9(2):223-33. PubMed ID: 3205432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lapatinib alleviates TOCP-induced axonal damage in the spinal cord of mouse.
    Xu HY; Sun YJ; Sun YY; Wu YJ; Xu MY; Chen LP; Zhu L
    Neuropharmacology; 2021 May; 189():108535. PubMed ID: 33766630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical, neuropathological and behavioral studies in hens induced by acute exposure of tri-ortho-cresyl phosphate.
    Nanda S; Tapaswi PK
    Int J Neurosci; 1995 Jun; 82(3-4):243-54. PubMed ID: 7558652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autophagy in Tri-o-cresyl Phosphate-Induced Delayed Neurotoxicity.
    Xu HY; Wang P; Sun YJ; Jiang L; Xu MY; Wu YJ
    J Neuropathol Exp Neurol; 2017 Jan; 76(1):52-60. PubMed ID: 28040792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute delayed neurotoxicity in hens dosed with tri-ortho-cresyl phosphate (TOCP): correlation between clinical ataxia and neuropathological findings.
    Prentice DE; Roberts NL
    Neurotoxicology; 1983; 4(2):271-6. PubMed ID: 6685266
    [No Abstract]   [Full Text] [Related]  

  • 18. Assessment of the delayed neurotoxic potential of isopropyl triphenylphosphate using a nontraditional testing strategy.
    Sprague GL; Castles TR; Bickford AA
    J Toxicol Environ Health; 1984; 14(5-6):773-88. PubMed ID: 6520887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Six-month daily treatment of sheep with neurotoxic organophosphorus compounds.
    Soliman SA; Svendsgaard D; Farmer JD; Curley A; Durham WF
    Toxicol Appl Pharmacol; 1983 Jul; 69(3):417-31. PubMed ID: 6192547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytoskeletal proteins as targets for organophosphorus compound and aliphatic hexacarbon-induced neurotoxicity.
    Abou-Donia MB; Lapadula DM; Suwita E
    Toxicology; 1988 May; 49(2-3):469-77. PubMed ID: 2836976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.